{
    "Trade/Device Name(s)": [
        "ISE Indirect Na, K, Cl for Gen.2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K053165",
    "Predicate Device Reference 510(k) Number(s)": [
        "K953239"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ"
    ],
    "Summary Letter Date": "December 14, 2005",
    "Summary Letter Received Date": "November 14, 2005",
    "Submission Date": "November 11, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1665"
    ],
    "Regulation Name(s)": [
        "Sodium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Hitachi automated analyzer family"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode (ISE)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Electrode",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Roche ISE Indirect Na, K, Cl for Gen.2 reagent and electrodes used with Roche Hitachi analyzers to quantitatively determine sodium, potassium, and chloride by ion-selective electrode method.",
    "Indications for Use Summary": "Quantitative determination of sodium, potassium, and chloride in serum, plasma, or urine for diagnosis and management of electrolyte and metabolic disorders.",
    "fda_folder": "Clinical Chemistry"
}